Clinical Trial: A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects

U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07084961) titled 'A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects' on July 17.

Brief Summary: An open-label, single-center, crossover study to evaluate the impact of administration timing of TS-172 on the pharmacodynamics in healthy adult male subjects.

Study Start Date: Aug. 05

Study Type: INTERVENTIONAL

Condition: Healthy Adult Male Subjects

Intervention: DRUG: TS-172

Oral administration of TS-172 20 mg immediately before meal

DRUG: TS-172

Oral administration of TS-172 20 mg immediately after meal

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Taisho Pharmaceutical Co., Ltd.

Disclaimer: Curated by HT Syndication....